Skip to main content

IPHA · Innate Pharma SA · Short Volume

Track IPHA — free
$1.87 -0.01 (-0.53%) At close · Sep 11
Market Cap
$208.88M
Shares
111.70M

Daily short-sale volume published by FINRA from its trade-reporting facilities. It measures how many shares were sold short each day as a share of total volume — a daily flow, not the total outstanding short position.

Short Volume

Date Short Volume Short Exempt Total Volume Short %
2026-09-11 1,309 0 3,629 36.1%
2026-09-10 4,628 0 5,418 85.4%
2026-09-09 11,464 0 14,398 79.6%
2026-09-08 2,694 0 9,952 27.1%
2026-09-04 1,730 0 2,940 58.9%
2026-09-03 882 0 2,947 29.9%
2026-09-02 824 0 4,490 18.4%
2026-09-01 785 0 7,795 10.1%
2026-08-31 777 0 1,324 58.7%
2026-08-28 4,828 0 6,046 79.8%
2026-08-27 896 0 4,504 19.9%
2026-08-26 1,475 0 2,215 66.6%
2026-08-25 3,064 0 5,052 60.7%
2026-08-24 7,348 0 28,646 25.7%
2026-08-21 4,721 7 12,758 37.0%
2026-08-20 3,651 0 11,507 31.7%
2026-08-19 2,140 0 4,529 47.2%
2026-08-18 6,857 0 12,923 53.1%
2026-08-17 28,428 4,234 71,922 39.5%
2026-08-14 18,066 10,888 44,759 40.4%
2026-08-13 11,809 0 75,541 15.6%
2026-08-12 86,835 1,683 165,941 52.3%
2026-08-11 45,451 2,946 130,731 34.8%
2026-08-10 600,570 2,318 1,154,044 52.0%
2026-08-07 287 0 1,508 19.0%
2026-08-06 931 0 2,919 31.9%
2026-08-05 105 0 1,614 6.5%
2026-08-04 300 0 1,050 28.6%
2026-08-03 119 0 2,799 4.3%
2026-07-31 503 0 2,074 24.3%
2026-07-30 590 0 5,737 10.3%
2026-07-29 1 0 649 0.2%
2026-07-28 225 0 4,378 5.1%
2026-07-27 1,407 0 2,137 65.8%
2026-07-24 285 0 1,074 26.5%
2026-07-23 394 0 4,042 9.7%
2026-07-22 560 0 1,820 30.8%
2026-07-21 145 0 727 19.9%
2026-07-20 1,065 0 1,639 65.0%
2026-07-17 2,124 0 2,763 76.9%
2026-07-16 858 0 4,286 20.0%
2026-07-15 567 0 2,007 28.3%
2026-07-14 388 0 2,164 17.9%
2026-07-13 3,330 0 4,458 74.7%
2026-07-10 1,647 0 7,283 22.6%
2026-07-09 791 0 1,600 49.4%
2026-07-08 670 0 2,744 24.4%
2026-07-07 1,786 0 4,690 38.1%
2026-07-06 1,861 0 2,518 73.9%
2026-07-02 558 0 2,414 23.1%
Showing 1–50 of 62 days
Key facts CIK 1598599 CUSIP 45781K204 13F (30d) 4 filings 4 filers Visit website Investor relations